Home › Funds › S&CO INC › RPRX

S&CO INC position in RPRX

ROYALTY PHARMA PLC · Health Care

S&CO INC reported holding 358,002 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$20.9M, representing 1.21% of its reported portfolio and ranking #23 among its reported holdings. S&CO INC has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)358.00K sh
Reported value held$20.89M
Portfolio Weight1.21%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How S&CO INC's RPRX position evolved

S&CO INC first disclosed a stake in RPRX in Q3 2023 at 253,610 shares (US$6.9M). The position peaked in Q3 2026 at 358,002 shares, worth US$20.9M. Across 13 filings, S&CO INC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 358,002 shares valued at US$20.9M. Notable position changes include a 31% increase in Q4 2023 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 253.61K $6.88M New
Q4 2023 332.11K $9.33M Add
Q1 2024 341.06K $10.36M Add
Q2 2024 358.26K $9.45M Add
Q3 2024 362.49K $10.25M Add
Q4 2024 358.16K $9.14M Reduce
Q1 2025 358.17K $11.15M Hold
Q2 2025 358.17K $12.90M Hold
Q3 2025 358.24K $12.64M Hold
Q4 2025 358.38K $13.85M Hold
Q1 2026 358.38K $17.19M Hold
Q2 2026 358.30K $20.09M Hold
Q3 2026 358.00K $20.89M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 48 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$598.8M), Baillie Gifford & Co (US$534.1M), ROYAL LONDON ASSET MANAGEMENT LTD (US$348.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has S&CO INC held RPRX?

S&CO INC has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is S&CO INC's current position in RPRX?

As of Q3 2026, S&CO INC holds 358.00K shares of RPRX (ROYALTY PHARMA PLC), valued at $20.89M, representing 1.21% of its reported portfolio and ranking #23.

Has S&CO INC been buying or selling RPRX?

In the latest 13F filing (Q3 2026), S&CO INC held unchanged its position in RPRX. The position peaked in Q3 2026 at 358.00K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, ROYAL LONDON ASSET MANAGEMENT LTD, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.